TIME-RESOLVED STUDY OF THE SUBPICOSECOND DYNAMICS OF MOLECULAR ROTATIONS IN LIQUIDS

Les résultats résolus dans le temps, sur la relaxation des rotations moléculaires dans les liquides sont rapportés. Dans CS2, en plus des 2 picosecondes du temps de relaxation de Debye, un temps de relaxation de 330 femtosecondes est observé pour la première fois. Ce court temps de relaxation est interprété comme étant dû à la relaxation des molécules dans les puits librationnels dans le liquide. Un temps de relaxation court similaire de l'ordre de 150 femtosecondes est aussi observé dans le nitrobenzène liquide.Time resolved results on the relaxation of molecular rotations in liquids are reported. In CS2, in addition to the 2 picosecond Debye relaxation time, a 330-femtosecond short relaxation time is observed for the first time. This short relaxation time is interpreted as due to the relaxation of the molecules within the librational wells in the liquid. A similar short relaxation time on the order of 150 femtoseconds is also observed in neat liquid nitrobenzene

Role of Vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group

Vitamin D is a key component for optimal growth and for calcium–phosphate homeostasis. Skin photosynthesis is the main source of vitamin D. Limited sun exposure and insufficient dietary vitamin D supply justify vitamin D supplementation in certain age groups. In older adults, recommended doses for vitamin D supplementation vary between 200 and 2000 IU/day, to achieve a goal of circulating 25-hydroxyvitamin D (calcifediol) of at least 50 nmol/L. The target level depends on the population being supplemented, the assessed system, and the outcome. Several recent large randomized trials with oral vitamin D regimens varying between 2000 and 100,000 IU/month and mostly conducted in vitamin D-replete and healthy individuals have failed to detect any efficacy of these approaches for the prevention of fracture and falls. Considering the well-recognized major musculoskeletal disorders associated with severe vitamin D deficiency and taking into account a possible biphasic effects of vitamin D on fracture and fall risks, an European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group convened, carefully reviewed, and analyzed the meta-analyses of randomized controlled trials on the effects of vitamin D on fracture risk, falls or osteoarthritis, and came to the conclusion that 1000 IU daily should be recommended in patients at increased risk of vitamin D deficiency. The group also addressed the identification of patients possibly benefitting from a vitamin D loading dose to achieve early 25-hydroxyvitamin D therapeutic level or from calcifediol administration

Fundamental aspects of light scattering and optical Kerr effect spectroscopy

We describe the principles of two spectroscopic methods of non-resonance light scattering (LS) and optical-Kerr-effect (OKE) spectroscopies in detail, and review basic but truly important phenomena observed by these two methods. Particularly, we focus on the following three experiments: 1) Response functions determined by frequency-domain LS and time-domain OKE spectroscopies, almost completely agree with each other, indicating that the quantum-mechanical fluctuation-dissipation theorem (QM-FDT) holds well in this system. 2) Femtosecond time responses of liquids clearly show an initial rise process even though they show an exponential response at a later time. This indicates that the Debye relaxation model does not hold in such an early time region. 3) From the measurement of the Stokes and anti-Stokes LS intensity ratios, it is found that the LS spectra of relaxation modes in liquids and solids are symmetric with respect to the spectral origin of the scattered light and hence the ratio does not satisfy the Boltzmann distribution rule expected from QM-FDT. These experimental results which contain apparently contradictory data are closely related with the nature of relaxation modes examined, which more or less assume a macroscopic character, and also with the physical basis of relaxation, which is inevitably connected to the observation problem of quantum mechanics. We discuss these points in relation to the physical reality of macroscopic quantity

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)

Many patients at increased risk of fractures do not take their medication appropriately, resulting in a substantial decrease in the benefits of drug therapy. Improving medication adherence is urgently needed but remains laborious, given the numerous and multidimensional reasons for non-adherence, suggesting the need for measurement-guided, multifactorial and individualized solutions. Introduction: Poor adherence to medications is a major challenge in the treatment of osteoporosis. This paper aimed to provide an overview of the consequences, determinants and potential solutions to poor adherence and persistence to osteoporosis medication. Methods: A working group was organized by the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal diseases (ESCEO) to review consequences, determinants and potential solutions to adherence and to make recommendations for practice and further research. A systematic literature review and a face-to-face experts meeting were undertaken. Results: Medication non-adherence is associated with increased risk of fractures, leading to a substantial decrease in the clinical and economic benefits of drug therapy. Reasons for non-adherence are numerous and multidimensional for each patient, depending on the interplay of multiple factors, suggesting the need for multifactorial and individualized solutions. Few interventions have been shown to improve adherence or persistence to osteoporosis treatment. Promising actions include patient education with counselling, adherence monitoring with feedback and dose simplification including flexible dosing regimen. Recommendations for practice and further research were also provided. To adequately manage adherence, it is important to (1) understand the problem (initiation, implementation and/or persistence), (2) to measure adherence and (3) to identify the reason of non-adherence and fix it. Conclusion: These recommendations are intended for clinicians to manage adherence of their patients and to researchers and policy makers to design, facilitate and appropriately use adherence interventions